Back
Catalyst Pharmaceuticals Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
60
CPRX
Catalyst Pharmaceuticals
Last Price:
$21.32
Seasonality Move:
24.6%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Catalyst Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.4 | Buy |
| 20-day SMA: | 21.63 | Sell |
| 50-day SMA: | 23.28 | Sell |
| 200-day SMA: | 22.41 | Sell |
| 8-day EMA: | 21.41 | Buy |
| 20-day EMA: | 21.89 | Sell |
| 50-day EMA: | 21.87 | Sell |
| 200-day EMA: | 13.01 | Buy |
Catalyst Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.57 | Sell |
| Relative Strength Index (14 RSI): | 41.72 | Sell |
| Chaikin Money Flow: | 916957 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21 - 23.22) | Sell |
| Bollinger Bands (100): | (21.62 - 24.54) | Sell |
Catalyst Pharmaceuticals Technical Analysis
| Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Catalyst Pharmaceuticals Stock
Is Catalyst Pharmaceuticals Stock a Buy?
-
Catalyst Pharmaceuticals share price is 21.45 while CPRX 8-day simple moving average is 21.40, which is a Buy signal.
-
The stock price of CPRX is 21.45 while Catalyst Pharmaceuticals 20-day SMA is 21.63, which makes it a Sell.
-
Catalyst Pharmaceuticals 50-day simple moving average is 23.28 while CPRX share price is 21.45, making it a Sell technically.
-
CPRX stock price is 21.45 and Catalyst Pharmaceuticals 200-day simple moving average is 22.41, creating a Sell signal.
CPRX Technical Analysis vs Fundamental Analysis
Buy
60
Catalyst Pharmaceuticals (CPRX)
is a Buy
Is Catalyst Pharmaceuticals a Buy or a Sell?
-
Catalyst Pharmaceuticals stock is rated a BuyThe current Catalyst Pharmaceuticals [CPRX] share price is $21.45. The Score for CPRX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
Catalyst Pharmaceuticals Stock Info
Market Cap:
2.6B
Price in USD:
21.45
Share Volume:
1.4M
Catalyst Pharmaceuticals 52-Week Range
52-Week High:
26.58
52-Week Low:
15.34
Buy
60
Catalyst Pharmaceuticals (CPRX)
is a Buy
Catalyst Pharmaceuticals Share Price Forecast
-
What is the Catalyst Pharmaceuticals stock price today?The Catalyst Pharmaceuticals stock price is 21.45 USD today.
-
Will CPRX stock go up or go down?Catalyst Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Catalyst Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Catalyst Pharmaceuticals is not overvalued.
Is Catalyst Pharmaceuticals Stock a Buy?
-
Catalyst Pharmaceuticals share price is 21.45 while CPRX 8-day exponential moving average is 21.41, which is a Buy signal.
-
The stock price of CPRX is 21.45 while Catalyst Pharmaceuticals 20-day EMA is 21.89, which makes it a Sell.
-
Catalyst Pharmaceuticals 50-day exponential moving average is 21.87 while CPRX share price is 21.45, making it a Sell technically.
-
CPRX stock price is 21.45 and Catalyst Pharmaceuticals 200-day simple moving average is 13.01, creating a Buy signal.
Fundamental Analysis of Catalyst Pharmaceuticals
Is Catalyst Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.17 per share, an increase this year of $0.04 per share, and an increase next year of $0.25 per share.
Technical Analysis of Catalyst Pharmaceuticals
Should I short Catalyst Pharmaceuticals stock?
-
CPRX Moving Average Covergence Divergence (MACD) indicator is -0.57, suggesting Catalyst Pharmaceuticals is a Sell
-
Catalyst Pharmaceuticals Relative Strength Index (RSI) is 41.72, which suggest Catalyst Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Catalyst Pharmaceuticals is (21 - 23.22), which suggest Catalyst Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Catalyst Pharmaceuticals is (21.62 - 24.54), which suggest Catalyst Pharmaceuticals is a Sell
* Catalyst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.